Heidi M. Mansour, PhD, assistant professor in the University of Arizona College of Pharmacy, is working to develop advanced dry powder inhalers to treat and prevent pulmonary diseases.
Feb 22, 2016
0
16
Individuals with depression are more than twice as likely to have hospitalizations that might be preventable with timely outpatient medical care in the community, a new study finds. In addition, after being discharged from ...
Dec 2, 2015
0
9
Persons who have had bronchiolitis in early childhood have an increased risk of asthma at the age of 28-31 and a weaker health-related quality of life than their peers. In lung function tests, they also demonstrate changes ...
Nov 23, 2015
0
1
A new study from the University of Texas Medical Branch at Galveston is the first to show that hydrogen sulfide, a gas produced naturally within our bodies, reduces the severity of respiratory syncytial virus, or RSV. When ...
Apr 27, 2015
0
9
Cancer patients are more likely to get infections. Pneumonia is the most frequent type of infection in this group and a frequent cause of ICU admission and mortality. A study conducted by researchers from the D'Or Institute ...
Apr 13, 2015
0
6
They're alive thanks to the most advanced care modern hospitals can provide. But for survivors of sepsis, the hospital door often looks like a revolving one, a new study shows. And many of the conditions that send them back ...
Mar 10, 2015
0
13
One of the roadblocks to the eradication of tuberculosis (TB) is the difficulty in identifying patients with latent TB infections (LTBI). Neither the tuberculin skin test (TST) nor interferon-gamma release assays (IGRAs) ...
Jan 6, 2015
0
9
(Medical Xpress)—As winter approaches doctors are warning that wet washing dried indoors can pose a serious health threat for people with weakened immune systems or severe asthma.
Nov 27, 2014
1
0
A new blood biomarker test that indicates whether bacteria is the cause of a patient's lung infection is now being studied at UPMC Presbyterian, launching a national multicenter trial. The information could help doctors decide ...
Nov 12, 2014
0
0
(HealthDay)—Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF).
Oct 16, 2014
0
0
